Ads
related to: novartis pharmaceuticals stockschwab.com has been visited by 100K+ users in the past month
Search results
Novartis (NVS) Stock Dips While Market Gains: Key Facts
Zacks via Yahoo Finance· 3 months agoNovartis (NVS) closed the latest trading day at $99.77, indicating a -1.58% change from the previous...
Novartis (NVS) Stock Moves 0.22%: What You Should Know
Zacks via Yahoo Finance· 5 months agoIn the latest market close, Novartis (NVS) reached $108.47, with a +0.22% movement compared to the...
Novartis (NVS) Chronic Myeloid Leukemia Drug Approved by EC
Zacks via Yahoo Finance· 2 years agoNovartis NVS announced that the European Commission (EC) has approved Scemblix (asciminib) for the...
Novartis (NVS) Increases Despite Market Slip: Here's What You Need to Know
Zacks via Yahoo Finance· 5 months agoNovartis (NVS) closed the latest trading day at $101, indicating a +0.03% change from the previous...
Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks via Yahoo Finance· 2 months agoNovartis (NVS) closed at $95.88 in the latest trading session, marking a +0.64% move from the prior...
Novartis' (NVS) Unit to Acquire Astellas' Rights of Mycamine
Zacks via Yahoo Finance· 1 year agoNovartis NVS announced that its generic arm, Sandoz, has signed an agreement to acquire worldwide...
Why Novartis Stock Slipped on Friday
Motley Fool· 11 months agoPharmaceutical companies depend on the patent protection they receive for their goods, so it's never a good day when it is stripped away. The latest...
Novartis (NVS) Spins off Sandoz, Reiterates Annual Outlook
Zacks via Yahoo Finance· 8 months agoNovartis NVS completed the spin-off of its generic and biosimilar unit, Sandoz, following which...
Novartis (NVS) Gains But Lags Market: What You Should Know
Zacks via Yahoo Finance· 11 months agoNovartis (NVS) closed at $97.16 in the latest trading session, marking a +0.63% move from the prior...
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo Finance· 11 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
